International Journal Of Drug Regulatory Affairs
  • Year: 2023
  • Volume: 11
  • Issue: 2

Drugs manufacturing license allocation (DMLA): An effective tool for e-governance in fields of drugs manufacturing regulation

  • Author:
  • Zuki Patel1, Shrikalp Deshpande1, Hemant Koshia2, Purva Patel2
  • Total Page Count: 6
  • Page Number: 58 to 63

1K. B. Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, India

2Food and Drugs Control Administration, First Floor, Block No. 8, Jivraj Mehta Bhavan, Gandhinagar, Gujarat, India

Online published on 15 July, 2023.

Abstract

Gujarat's Food & Drug Control Agency (FDCA) oversees the manufacturing and sales of food, drugs, and cosmetics. The FDCA is the organisation in charge of giving licences to parties involved in the production and sale of pharmaceuticals and related goods, such as drug makers, wholesalers, retailers, stockists, C&F agents, etc. The enforcement mission is to achieve the goal of making safe and effective medications available by ensuring that the menace of the production of fake/substandard drugs is eliminated. Access to information that is current and accurate, as well as the ability to speak with stakeholders clearly and promptly, are essential for enforcement actions. The enforcement task was dependent on manual methods before the initiative to incorporate software, SMS notifications, etc. The initiative “DMLA- Drugs Manufacturing License Allocation” is a web based IT solution, http://dmla.guj.nic.in/mfg/myaccount/Home.aspx, with data stored in the central server. The introduction of the new system has strengthened the enforcement function. It has helped to achieve and maintain FDCA's leadership in drug regulation in India by bringing consistency, speed, accuracy, effectiveness, accountability, and transparency to G2G, G2C, and G2B operations.

Keywords

Gujarat's Food & Drug Control Agency (FDCA), DMLA- Drugs Manufacturing License Allocation, IDMLA portal, DCGI